Thus, the presence of a specific cluster of immune soluble factors in the CSF composed by potential protective factors as IL-9, IL-1ra, IL-15, and VEGF in progressive MS could represent an attempt of the immune system to counteract the pro-inflammatory environment regulated by the factors of group 1. The gene discussed is IL15; the disease is myeloid sarcoma.